Takeo Kosaka (Eiji Kikuchi)

Scopus Author ID Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 22

Top Topics

Editorial Comment

Reactive Oxygen Species

Squamous Cell Carcinoma

Top Venues

International journal of urology : official journal of the Japanese Urological Association

The EMBO journal

IJU case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Kazuhiro Matsumoto, Masanori Hasegawa, Takako Hishiki, Yoshiko Naito, Yuto Baba, Shuji Mikami, Kazuhiro Matsumoto, Ryuichi Mizuno, Akira Miyajima, Eiji Kikuchi, Hideyuki Saya, Takeo Kosaka, Mototsugu Oya
IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer. The EMBO journal 42 (4) (2023)
Takeo Kosaka, Nozomi Hayakawa
Editorial Comment to "The poor antitumor effect of pembrolizumab in advanced upper urothelial carcinoma with renal parenchymal invasion". International journal of urology : official journal of the Japanese Urological Association (2023)
Kazuhiro Matsumoto, Masanori Hasegawa, Takako Hishiki, Yoshiko Naito, Yuto Baba, Shuji Mikami, Kazuhiro Matsumoto, Ryuichi Mizuno, Akira Miyajima, Eiji Kikuchi, Hideyuki Saya, Takeo Kosaka, Mototsugu Oya
IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer. The EMBO journal 42 (4) (2023)
Takeo Kosaka, Chi-Fai Ng, Hiroshi Kitamura, Ja Hyeon Ku, Lui-Shiong Lee, Tzu-Ping Lin, Junice Yi Siu Ng, Hiroyuki Nishiyama, Darren Ming-Chun Poon, Ravindran Kanesvaran, Ho Kyung Seo, Carmel Spiteri, Ee Min Tan, Yuh-Shyan Tsai, Ben Tran
Controversies in terminology associated with management of BCG-unresponsive NMIBC in Asia-Pacific. International journal of urology : official journal of the Japanese Urological Association (2023)
Kazuhiro Matsumoto, Masanori Hasegawa, Takako Hishiki, Yoshiko Naito, Yuto Baba, Shuji Mikami, Kazuhiro Matsumoto, Ryuichi Mizuno, Akira Miyajima, Eiji Kikuchi, Hideyuki Saya, Takeo Kosaka, Mototsugu Oya
IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer. The EMBO journal (2023)
Hyeong Dong Yuk, Lui-Shiong Lee, Tzu-Ping Lin, Takeo Kosaka, Hiroshi Kitamura, Chi-Fai Ng, Junice Yi Siu Ng, Darren Ming-Chun Poon, Ravindran Kanesvaran, Ho Kyung Seo, Carmel Spiteri, Ee Min Tan, Ben Tran, Yuh-Shyan Tsai, Hiroyuki Nishiyama
Risk stratification and management of non-muscle-invasive bladder cancer: A physician survey in six Asia-Pacific territories. International journal of urology : official journal of the Japanese Urological Association (2023)
Kazuhiro Matsumoto, Masanori Hasegawa, Takako Hishiki, Yoshiko Naito, Yuto Baba, Shuji Mikami, Kazuhiro Matsumoto, Ryuichi Mizuno, Akira Miyajima, Eiji Kikuchi, Hideyuki Saya, Takeo Kosaka, Mototsugu Oya
IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer. The EMBO journal 42 (4) (2023)
Takeo Kosaka, Nozomi Hayakawa
Editorial Comment to "Improving compliance with guidelines may lead to favorable clinical outcomes for patients with non-muscle-invasive bladder cancer: A retrospective multicenter study". International journal of urology : official journal of the Japanese Urological Association (2023)
Kazuhiro Matsumoto, Masanori Hasegawa, Takako Hishiki, Yoshiko Naito, Yuto Baba, Shuji Mikami, Kazuhiro Matsumoto, Ryuichi Mizuno, Akira Miyajima, Eiji Kikuchi, Hideyuki Saya, Takeo Kosaka, Mototsugu Oya
IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer. The EMBO journal 42 (4) (2023)
Kazuhiro Matsumoto, Masanori Hasegawa, Takako Hishiki, Yoshiko Naito, Yuto Baba, Shuji Mikami, Kazuhiro Matsumoto, Ryuichi Mizuno, Akira Miyajima, Eiji Kikuchi, Hideyuki Saya, Takeo Kosaka, Mototsugu Oya
IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer. The EMBO journal 42 (4) (2023)
Nozomi Hayakawa, Takeo Kosaka
A case of pseudoprogression in avelumab maintenance therapy for metastatic bladder cancer. IJU case reports 6 (1) (2022)
Makito Miyake, Takeo Kosaka, Kenta Shinozaki, Yi Piao, Nobuya Hayashi, Ryo Koto, Masahisa Jinushi, Takashi Kobayashi
Real-world treatment patterns and clinical outcomes of Japanese patients with non-muscle invasive bladder cancer receiving intravesical bacillus Calmette-Guérin treatment. International journal of urology : official journal of the Japanese Urological Association 29 (10) (2022)
Frederik König, Nico Christian Grossmann, Francesco Soria, David D Andrea, Tristan Juvet, Aaron Potretzke, Hooman Djaladat, Alireza Ghoreifi, Takeo Kosaka, Nozomi Hayakawa, Andrea Mari, Zine-Eddine Khene, Kazutoshi Fujita, Jay D Raman, Alberto Breda, Matteo Fontana, John P Sfakianos, John L Pfail, Ekaterina Laukhtina, Pawel Rajwa, Maximilian Pallauf, Giovanni Enrico Cacciamani, Thomas van Doeveren, Joost L Boormans, Alessandro Antonelli, Marcus Jamil, Firas Abdollah, Jeffrey Budzyn, Guillaume Ploussard, Axel Heidenreich, Siamak Daneshmand, Stephen A Boorjian, Morgan Rouprêt, Michael Rink, Shahrokh F Shariat, Benjamin Pradere
Pentafecta for Radical Nephroureterectomy in Patients with High-Risk Upper Tract Urothelial Carcinoma: A Proposal for Standardization of Quality Care Metrics. Cancers 14 (7) (2022)
Nozomi Hayakawa, Takeo Kosaka
Editorial Comment from Dr Hayakawa and Dr Kikuchi to Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study). International journal of urology : official journal of the Japanese Urological Association 29 (7) (2022)
Yuta Kaneko, Takeo Kosaka, Kohei Nakamura, Shuji Mikami, Hiroshi Nishihara, Mototsugu Oya
Squamous cell carcinoma of the prostate with SMARCA4 alteration in a Japanese patient. IJU case reports 5 (5) (2022)
Tetsushi Murakami, Takeo Kosaka, Hiroki Ide, Yuta Umezawa, Takayuki Takahashi, Mizuki Izawa, Kyohei Hakozaki, Keisuke Shigeta, Koichiro Ogihara, Hiroaki Kobayashi, Kunimitsu Kanai, Takahiro Maeda, Shunsuke Yoshimine, Ryuichi Mizuno, Koshiro Nishimoto, Mototsugu Oya
Oncological outcomes of dose reductions in cisplatin due to renal dysfunction for patients with metastatic urothelial carcinoma. BJUI compass 2 (5) (2021)
Nozomi Hayakawa, Takeo Kosaka
Editorial Comment to Incidence and location of perioperative deep vein thrombosis in patients with bladder cancer undergoing radical cystectomy. International journal of urology : official journal of the Japanese Urological Association 29 (3) (2021)
Kazuhiro Matsumoto, Kazuhiro Matsumoto, Koichiro Ogihara, Tetsushi Murakami, Tadatsugu Anno, Kota Umeda, Mizuki Izawa, Yuto Baba, Tansei Sanjo, Kazunori Shojo, Nobuyuki Tanaka, Toshikazu Takeda, Takeo Kosaka, Ryuichi Mizuno, Shuji Mikami, Takeo Kosaka, Mototsugu Oya
The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma. Cancer science 112 (3) (2021)
Yuto Baba, Takeo Kosaka, Keisuke Shigeta, Koichiro Ogihara, Masashi Matsushima, Yui Nishimoto, Yasuaki Murata, Hirotaka Asakura, Masafumi Oyama, Ryuichi Mizuno, Mototsugu Oya
Effects of transurethral resection under general anesthesia on tumor recurrence in non-muscle invasive bladder cancer. International journal of clinical oncology 26 (11) (2021)
Kazuhiro Matsumoto, Masanori Hasegawa, Takeo Kosaka, Yota Yasumizu, Takeo Kosaka, Ryuichi Mizuno, Shuji Mikami, Akira Miyajima, Donald Kufe, Mototsugu Oya
Role of the MUC1-C oncoprotein in the acquisition of cisplatin resistance by urothelial carcinoma. Cancer science 111 (10) (2020)
Kimiharu Takamatsu, Toshikazu Takeda, Seiya Hattori, Nobuyuki Tanaka, Shinya Morita, Kazuhiro Matsumoto, Takeo Kosaka, Ryuichi Mizuno, Toshiaki Shinojima, Takeo Kosaka, Hiroshi Asanuma, Isao Kurihara, Hiroshi Itoh, Mototsugu Oya
Appropriate timing for a biochemical evaluation after adrenalectomy for unilateral aldosterone-producing adenoma. Clinical endocrinology 92 (6) (2020)
Koichiro Ogihara, Takeo Kosaka, Shogo Okazaki, Masayuki Hagiwara, Toshikazu Takeda, Kazuhiro Matsumoto, Takeo Kosaka, Shuji Mikami, Hideyuki Saya, Mototsugu Oya
Sulfasalazine could modulate the CD44v9-xCT system and enhance cisplatin-induced cytotoxic effects in metastatic bladder cancer. Cancer science 110 (4) (2019)